Clinical Significance of HER2 Overexpression in Gastric and Gastroesophageal Junction Cancers


Baykara M., Benekli M., EKİNCİ Ö., Irkkan S. C., Karaca H., Demirci U., ...Daha Fazla

JOURNAL OF GASTROINTESTINAL SURGERY, cilt.19, sa.9, ss.1565-1571, 2015 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 19 Sayı: 9
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1007/s11605-015-2888-y
  • Dergi Adı: JOURNAL OF GASTROINTESTINAL SURGERY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1565-1571
  • Anahtar Kelimeler: GC, GEJCs, HER2, Prognosis, C-ERBB-2 PROTEIN EXPRESSION, C-ERB B-2, PROGNOSTIC-SIGNIFICANCE, GENE AMPLIFICATION, CLINICOPATHOLOGICAL FEATURES, GROWTH, TRASTUZUMAB, CARCINOMAS, SURVIVAL, ADENOCARCINOMA
  • Gazi Üniversitesi Adresli: Evet

Özet

In this study, we investigated the rate of human epidermal growth factor receptor 2 (HER2) overexpression in gastric (GC) and gastroesophageal junction cancers (GEJCs) and the relationship with HER2 expression and clinical, pathological parameters and prognosis.